Therapy - Hodgkin's Disease
"Cyclophosphamide, BCNU, and VP-16 Followed by Autologous Bone Marrow or Peripheral Blood Stem Cell Transplantation in Hodgkin's Disease (HD), Retrospective Analysis of 1
Published in Cancer Weekly, March 6th, 1995
According to an abstract submitted by the authors to the 36th Annual Meeting of the American Society of Hematology, held December 2-6, 1994, in Nashville, Tennessee, "From January/84 to December/93, 254 patients (pts) (155 male, 99 female) with HD have been treated at the UNMC, with Cyclophosphamide (1.5 g/m2/dx4; d-6 to d-3), VP-16 (125 -150 mg/m2 q 12hx6; d-6 to d-4), and BCNU (300 mg/m2x1; d-6) (CBV) followed by autologous bone marrow (ABMT) (156 pts) or peripheral blood stem cell transplantation (PBSCT) (98 pts). Median age was 31 (range: 15-43). Two hundred ten pts had a-history of remission after initial chemotherapy (CHX), but relapsed. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1995-03-06)
More Articles from Cancer Weekly
- Cancer/Gene Therapy
Adoptive Immunotherapy by Gene Transfection for Metastatic Disease Treatment - Cancer/Gene Therapy
Retroviral-Mediated Gene Transfer Enhances Antitumor Immunity - Cancer/Gene Therapy
"Suicide Gene" Shows Promise Against Localized Gliomas - Cervical Cancer
Blood Test Detects Virus Linked to Cancer - Colorectal
Alcohol and Smoking Cited As Risk Factors for Polyps - Conference Coverage
Advances in Prognostic Evaluation of Cervical Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
